SCLX Stock Analysis: Buy, Sell, or Hold?
SCLX - Scilex Holding Company Common Stock
$8.44
-0.35 (-3.98%)
▼
5d:
-10.97%
30d:
+43.54%
90d:
+28.07%
WAIT
LOW Confidence
Analysis Updated: Jul 17, 2026 12:00 AM ET
Earnings: Aug 12, 2026
24d
Get Alerted When SCLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: SCLX is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: SCLX is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.16
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.45
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SCLX is currently trading at $8.44, which is considered fair relative to its 30-day fair value range of $7.06 to $9.07. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.6) compared to its historical average (7.0). At these levels, the market is pricing in 18.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SCLX is showing sideways momentum. Immediate support is located at $7.01, while resistance sits at $10.43. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: SCLX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $490.00 (+5705.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SCLX is showing sideways momentum. Immediate support is located at $7.01, while resistance sits at $10.43. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: SCLX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $490.00 (+5705.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.06 -
$9.07
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 5705.7% below Wall St target ($490.00)
- NEUTRAL: Trading at premium valuation - market expects 18.1% growth which is achievable
- WARNING: Recommendation downgraded due to -11.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$7.06 -
$9.07
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$7.01
Resistance Level
$10.43
Current Trend
Sideways
Technical data as of
Jul 17, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.56
Wall Street Target
$490.00
(+5705.7%)
Revenue Growth (YoY)
72.1%
Valuation Premium vs History
+18.1% premium
PE vs Historical
11.6 vs 7.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+18.1%
(market-implied from PE analysis)
1-Year Target
$9.97
(+18%)
2-Year Target
$11.77
(+40%)
3-Year Target
$13.90
(+65%)
3-Yr Target (if PE normalizes)
(PE: 12→7)
PE COMPRESSION
$8.42
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: July 18, 2026 5:26 PM ET
Data refreshes hourly during market hours. Next update: 6:26 PM
Data refreshes hourly during market hours. Next update: 6:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SCLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1240 | 59 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$158 | 66 BUY |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$263 | 64 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$356 | 62 BUY |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$223 | 55 HOLD |
